Skip to main content

VACUNAS BASADAS EN LA INMUNIDAD ENTRENADA ORIENTADA USANDO STREPTOCOCCUS SUIS COMO MODELO EXPERIMENTAL (TAIV-SUIS)

PID2020-112966RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

  • Sánchez Morales, Lidia
  • Porras, Néstor
  • García Seco, Teresa
  • Pérez Sancho, Marta
  • Cruz, Fátima
  • Chinchilla, Blanca
  • Barroso Arévalo, Sandra
  • Díaz Frutos, Marta
  • Buendía, Aránzazu
  • Moreno, Inmaculada
  • Briones, Víctor
  • Risalde, María A.
  • Fuente, José de la
  • Juste, Ramón Antonio
  • Garrido, Joseba M.
  • Balseiro Morales, Ana María
  • Gortázar, Christian
  • Rodríguez Bertos, Antonio
  • Domínguez, Mercedes
  • Domínguez, Lucas
[EN] In the wake of the COVID-19 pandemic caused by SARS-CoV-2, questions emerged about the potential effects of Bacillus Calmette-Guérin (BCG) vaccine on the immune response to SARS-CoV-2 infection, including the neurodegenerative diseases it may contribute to. To explore this, an experimental study was carried out in BCG-stimulated and non-stimulated k18-hACE2 mice challenged with SARS-CoV-2. Viral loads in tissues determined by RT-qPCR, histopathology in brain and lungs, immunohistochemical study in brain (IHC) as well as mortality rates, clinical signs and plasma inflammatory and coagulation biomarkers were assessed. Our results showed BCG-SARS-CoV-2 challenged mice presented higher viral loads in the brain and an increased frequency of neuroinvasion, with the greatest differences observed between groups at 3-4 days post-infection (dpi). Histopathological examination showed a higher severity of brain lesions in BCG-SARS-CoV-2 challenged mice, mainly consisting of neuroinflammation, increased glial cell population and neuronal degeneration, from 5 dpi onwards. This group also presented higher interstitial pneumonia and vascular thrombosis in lungs (3-4 dpi), BCG-SARS-CoV-2 mice showed higher values for TNF-α and D-dimer values, while iNOS values were higher in SARS-CoV-2 mice at 3-4 dpi. Results presented in this study indicate that BCG stimulation could have intensified the inflammatory and neurodegenerative lesions promoting virus neuroinvasion and dissemination in this experimental model. Although k18-hACE2 mice show higher hACE2 expression and neurodissemination, this study suggests that, although the benefits of BCG on enhancing heterologous protection against pathogens and tumour cells have been broadly demonstrated, potential adverse outcomes due to the non-specific effects of BCG should be considered, SI, This research was partially funded by a REACT-European Union grant from the Comunidad de Madrid to the ANTICIPA project of Complutense University of Madrid (reference PR38/21) and partially funded by PID2020-112966RB-I00 financed by MCIN/AEI/10.13039/501100011033. The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Exploring trained immunity to complement vaccination against Streptococcus suis in swine

  • Sánchez Morales, Lidia
  • Pérez Sancho, Marta
  • García Seco, Teresa
  • Balseiro Morales, Ana María
  • Pérez Domingo, Andrea
  • Buendía, Aránzazu
  • Díez Guerrier, Alberto
  • Garnica García, María Gracia de
  • Mareque, Patricia
  • Risalde, María de los Ángeles
  • Gortázar, Christian
  • Domínguez, Mercedes
  • Domínguez, Lucas
[EN] Streptococcus suis is a major pathogen in swine, causing septicaemia, meningitis, and arthritis. Effective control is complicated by the presence of multiple serotypes, genetic heterogeneity, and interference of maternal antibodies with vaccine efficacy. Moreover, the emergence of antibiotic-resistant strains poses additional challenges. Trained immunity, a process of innate immune memory induced by certain stimuli, has been proposed as a novel approach to enhance host defense mechanisms. This study aimed to evaluate whether a mycobacterial-derived immunomodulator (dpB) administered with a specific S. suis vaccine could improve protection in pigs. Thirty-two weaned pigs were allocated into four groups: vaccine alone, vaccine and live dpB, vaccine and inactivated dpB, and non-immunized controls. After two immunizations, animals were challenged with a S. suis serotype 2 strain. Immune responses were assessed through ex vivo blood stimulation, cytokine measurement and phagocytosis assays. The group receiving vaccine and inactivated dpB presented a better response, including reduced bacterial loads in tissues, less severe lung lesions and elevated pre-challenge cytokine levels. Clinically, these animals showed milder symptoms and lower bacterial dissemination post-challenge. While trained immunity remains a relatively new concept in veterinary immunology, these results suggest that inactivated dpB, when combined with specific vaccination, could serve as an effective complementary strategy to improve protection against S. suis . Further research is needed to elucidate the underlying mechanisms and to establish its potential role in comprehensive disease prevention programs, SI, LSM holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. This research was funded by PID2020-112966RB-I00 project financed by MCIN/AEI/10.13039/ 501100011033 (TAIV-suis)
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

The impact of mycobacteria-induced trained immunity on SARS-CoV-2 vaccine responses

  • Sánchez Morales, Lidia
  • Porras, Néstor
  • Pérez Domingo, Andrea
  • Pérez Sancho, Marta
  • García Seco, Teresa
  • Díaz Frutos, Marta
  • Buendía, Aránzazu
  • Moreno, Inmaculada
  • Zamora, Leydis
  • Balseiro Morales, Ana María
  • Risalde, María A.
  • Rodríguez Bertos, Antonio
  • Gortázar, Christian
  • Domínguez, Mercedes
  • Domínguez, Lucas
[EN] Introduction: Beyond the role of Bacillus Calmette-Guérin (BCG) for tuberculosis prevention, BCG has demonstrated heterologous protective effects. The global health crisis caused by the SARS-CoV-2 virus led to research on whether BCG-induced trained immunity could strengthen antiviral defenses. However, studies reported quite different results on its effect against COVID-19. Methods and results: In this study, we evaluated the impact of pre-existing trained immunity induced by a BCG-derived Mycobacterium bovis strain (dpB), in both live and inactivated forms, in combination with SARS-CoV-2 vaccination prior to challenge in a mouse model. While the SARS-CoV-2 vaccine was enough for protection in morbidity and mortality terms, its combination with live dpB significantly enhanced immune responses reflected in higher levels of pro-inflammatory cytokines, reduced pulmonary viral loads, and improved histopathological outcomes. Additionally, the formation of inducible bronchus-associated lymphoid tissue (iBALT) in lungs in vaccinated animals pre-exposed to live dpB points to a potential mechanism for long-term immune surveillance in the respiratory tract. Conclusions: These immunological findings highlight the potential benefits of integrating trained immunity inducers with pathogen-specific vaccines to enhance immune responses and protection. Further research is needed to optimize immunomodulation strategies, dosing regimens and administration routes to maximize these synergistic effects and prevent potential negative effects, SI, The author(s) declare financial support was received for the research and/or publication of this article. LS-M holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. LZ holds a PTA2021-021020-I funded by MICIU/AEI/10.13039/501100011033 and FSE+. This research was partially funded by a REACT-European Union grant from the Comunidad de Madrid to the ANTICIPA project of Complutense University of Madrid (reference PR38/21). Mycobacteria production was partially funded by PID2020- 112966RB-I00 financed by MCIN/AEI/10.13039/501100011033.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

  • Sánchez-Morales, Lidia
  • Porras, Néstor
  • García-Seco, Teresa
  • Pérez-Sancho, Marta
  • Cruz, Fátima
  • Chinchilla, Blanca
  • Barroso-Arévalo, Sandra
  • Díaz-Frutos, Marta
  • Buendía-Andrés, Aránzazu
  • Moreno, Inmaculada
  • Briones, Víctor
  • Risalde, María Ángeles
  • Fuente, José de la
  • Juste, Ramón A.
  • Garrido, Joseba M.
  • Balseiro, Ana
  • Gortázar, Christian
  • Rodríguez-Bertos, Antonio
  • Domínguez, Mercedes
  • Domínguez, Lucas
In the wake of the COVID-19 pandemic caused by SARS-CoV-2, questions emerged about the potential effects of Bacillus Calmette-Guérin (BCG) vaccine on the immune response to SARS-CoV-2 infection, including the neurodegenerative diseases it may contribute to. To explore this, an experimental study was carried out in BCG-stimulated and non-stimulated k18-hACE2 mice challenged with SARS-CoV-2. Viral loads in tissues determined by RT-qPCR, histopathology in brain and lungs, immunohistochemical study in brain (IHC) as well as mortality rates, clinical signs and plasma inflammatory and coagulation biomarkers were assessed. Our results showed BCG-SARS-CoV-2 challenged mice presented higher viral loads in the brain and an increased frequency of neuroinvasion, with the greatest differences observed between groups at 3-4 days post-infection (dpi). Histopathological examination showed a higher severity of brain lesions in BCG-SARS-CoV-2 challenged mice, mainly consisting of neuroinflammation, increased glial cell population and neuronal degeneration, from 5 dpi onwards. This group also presented higher interstitial pneumonia and vascular thrombosis in lungs (3-4 dpi), BCG-SARS-CoV-2 mice showed higher values for TNF-α and D-dimer values, while iNOS values were higher in SARS-CoV-2 mice at 3-4 dpi. Results presented in this study indicate that BCG stimulation could have intensified the inflammatory and neurodegenerative lesions promoting virus neuroinvasion and dissemination in this experimental model. Although k18-hACE2 mice show higher hACE2 expression and neurodissemination, this study suggests that, although the benefits of BCG on enhancing heterologous protection against pathogens and tumour cells have been broadly demonstrated, potential adverse outcomes due to the non-specific effects of BCG should be considered., This research was partially funded by a REACT-European Union grant from the Comunidad de Madrid to the ANTICIPA project of Complutense University of Madrid (reference PR38/21) and partially funded by PID2020-112966RB-I00 financed by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The impact of mycobacteria-induced trained immunity on SARS-CoV-2 vaccine responses

  • Sánchez-Morales, Lidia
  • Porras, Néstor
  • Pérez-Domingo, Andrea
  • Pérez-Sancho, Marta
  • García-Seco, Teresa
  • Díaz-Frutos, Marta
  • Buendia, Aranzazu
  • Moreno, Inmaculada
  • Zamora, Leydis
  • Balseiro, Ana
  • Risalde, María Ángeles
  • Rodriguez-Bertos, Antonio
  • Gortázar, Christian
  • Domínguez, Mercedes
  • Domínguez, Lucas
17 páginas, 9 figuras, 2 tablas., Beyond the role of Bacillus Calmette-Guérin (BCG) for tuberculosis prevention, BCG has demonstrated heterologous protective effects. The global health crisis caused by the SARS-CoV-2 virus led to research on whether BCG-induced trained immunity could strengthen antiviral defenses. However, studies reported quite different results on its effect against COVID-19., The author(s) declare financial support was received for the research and/or publication of this article. LS-M holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. LZ holds a PTA2021-021020-I funded by MICIU/AEI/10.13039/501100011033 and FSE+. This research was partially funded by a REACT-European Union grant from the Comunidad de Madrid to the ANTICIPA project of Complutense University of Madrid (reference PR38/21). Mycobacteria production was partially funded by PID2020- 112966RB-I00 financed by MCIN/AEI/10.13039/501100011033., Authors would like to thank Marıa del Carmen Jimenez for her ́ excellent technical support. We would like to thank Luis Enjuanes for kindly providing the SARS-CoV-2 virus, the ISCIII, for their support in the cytokine analysis and MYCOTRAINING group for their support in the development of the present study, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Exploring trained immunity to complement vaccination against Streptococcus suis in swine

  • Sánchez-Morales, Lidia
  • Pérez-Sancho, Marta
  • García-Seco, Teresa
  • Balseiro, Ana
  • Pérez-Domingo, Andrea
  • Buendía, Aránzazu
  • Diez-Guerrier, Alberto
  • Garnica García, M. Gracia de
  • Mareque, Patricia
  • Risalde, María Ángeles
  • Gortázar, Christian
  • Domínguez, Mercedes
  • Domínguez, Lucas
12 páginas, 8 figuras, 2 tablas., Streptococcus suis is a major pathogen in swine, causing septicaemia, meningitis, and arthritis. Effective control is complicated by the presence of multiple serotypes, genetic heterogeneity, and interference of maternal antibodies with vaccine efficacy. Moreover, the emergence of antibiotic-resistant strains poses additional challenges. Trained immunity, a process of innate immune memory induced by certain stimuli, has been proposed as a novel approach to enhance host defense mechanisms. This study aimed to evaluate whether a mycobacterial-derived immunomodulator (dpB) administered with a specific S. suis vaccine could improve protection in pigs. Thirty-two weaned pigs were allocated into four groups: vaccine alone, vaccine and live dpB, vaccine and inactivated dpB, and non-immunized controls. After two immunizations, animals were challenged with a S. suis serotype 2 strain. Immune responses were assessed through ex vivo blood stimulation, cytokine measurement and phagocytosis assays. The group receiving vaccine and inactivated dpB presented a better response, including reduced bacterial loads in tissues, less severe lung lesions and elevated pre-challenge cytokine levels. Clinically, these animals showed milder symptoms and lower bacterial dissemination post-challenge. While trained immunity remains a relatively new concept in veterinary immunology, these results suggest that inactivated dpB, when combined with specific vaccination, could serve as an effective complementary strategy to improve protection against S. suis. Further research is needed to elucidate the underlying mechanisms and to establish its potential role in comprehensive disease prevention programs., LSM holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. This research was funded by PID2020-112966RB-I00 project financed by MCIN/AEI/10.13039/501100011033 (TAIV-suis)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Evaluation of trained immunity as a potential strategy for a universal Streptococcus suis vaccine using immunogenic proteins in a murine model

  • Sánchez-Morales, Lidia
  • Zamora, Leydis
  • Pérez-Sancho, Marta
  • García-Seco, Teresa
  • Moreno, Inmaculada
  • Pérez-Domingo, Andrea
  • Díaz-Frutos, Marta
  • Ciordia, Sergio
  • Buendía, Aránzazu
  • de Los Ángeles Risalde, María
  • Domínguez, Mercedes
  • Domínguez, Lucas
Universal vaccine against Streptococcus suis (S. suis) remains a challenge due to the high number of serotypes/strains, the absence of cross-protection among them and the existence of different immune escape strategies. In this study, the immunomodulatory potential of live and inactivated porcine derived Bacillus Calmette-Guérin (dpB) in combination with specific immunogenic proteins S. suis is evaluated in murine model., LSM holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. LZ holds a PTA2021-021020-I funded by MICIU/AEI /https://doi.org/10.13039/501100011033 and FSE+. This research was funded by PID2020-112966RB-I00 project financed by MCIN/AEI/10.13039/501100011033 (TAIV-suis)., Peer reviewed, Modelo experimental animal, Mamíferos - Roedores, Organismos alternativos no vertebrados - Microorganismos Unicelulares - Bacterias
Docta Complutense
Publication Artículo científico (JournalArticle)

Exploring trained immunity to complement vaccination against Streptococcus suis in swine

  • Sánchez Morales, Lidia
  • Pérez Sancho, Marta
  • García-Seco Romero, María Teresa
  • Balseiro, Ana
  • Pérez-Domingo, Andrea
  • Buendía, Aránzazu
  • Díez Guerrier, Alberto Antoine
  • de Garnica García, María García
  • Mareque, Patricia
  • de los Ángeles Risalde, María
  • Gortázar, Christian
  • Domínguez, Mercedes
  • Domínguez Rodríguez, Lucas José
Streptococcus suis is a major pathogen in swine, causing septicemia, meningitis, and arthritis. Effective control is complicated by the presence of multiple serotypes, genetic heterogeneity, and interference of maternal antibodies with vaccine efficacy. Moreover, the emergence of antibiotic-resistant strains poses additional challenges. Trained immunity, a process of innate immune memory induced by certain stimuli, has been proposed as a novel approach to enhance host defense mechanisms. This study aimed to evaluate whether a mycobacterial-derived immunomodulator (dpB) administered with a specific S. suis vaccine could improve protection in pigs. Thirty-two weaned pigs were allocated into four groups: vaccine alone, vaccine and live dpB, vaccine and inactivated dpB, and non-immunized controls. After two immunizations, animals were challenged with a S. suis serotype 2 strain. Immune responses were assessed through ex vivo blood stimulation, cytokine measurement and phagocytosis assays. The group receiving vaccine and inactivated dpB presented a better response, including reduced bacterial loads in tissues, less severe lung lesions and elevated pre-challenge cytokine levels. Clinically, these animals showed milder symptoms and lower bacterial dissemination post-challenge. While trained immunity remains a relatively new concept in veterinary immunology, these results suggest that inactivated dpB, when combined with specific vaccination, could serve as an effective complementary strategy to improve protection against S. suis. Further research is needed to elucidate the underlying mechanisms and to establish its potential role in comprehensive disease prevention programs
Docta Complutense
Publication Artículo científico (JournalArticle)

Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

  • Sánchez Morales, Lidia
  • Porras González, Néstor
  • García-Seco Romero, María Teresa
  • Pérez Sancho, Marta
  • Cruz López, Fátima
  • Chinchilla Rodríguez, Blanca
  • Barroso Arévalo, Sandra
  • Díaz Frutos, Marta
  • Buendía Andrés, Aránzazu
  • Moreno, Inmaculada
  • Briones Dieste, Víctor
  • Risalde, María A.
  • De la Fuente, José
  • Juste, Ramón
  • Garrido, Joseba
  • Balseiro, Ana
  • Gortázar, Christian
  • Rodríguez Bertos, Antonio Manuel
  • Domínguez, Mercedes
  • Domínguez Rodríguez, Lucas José
In the wake of the COVID-19 pandemic caused by SARS-CoV-2, questions emerged about the potential effects of Bacillus Calmette-Guérin (BCG) vaccine on the immune response to SARS-CoV-2 infection, including the neurodegenerative diseases it may contribute to. To explore this, an experimental study was carried out in BCG-stimulated and non-stimulated k18-hACE2 mice challenged with SARS-CoV-2. Viral loads in tissues determined by RT-qPCR, histopathology in brain and lungs, immunohistochemical study in brain (IHC) as well as mortality rates, clinical signs and plasma inflammatory and coagulation biomarkers were assessed. Our results showed BCG-SARS-CoV-2 challenged mice presented higher viral loads in the brain and an increased frequency of neuroinvasion, with the greatest differences observed between groups at 3–4 days post-infection (dpi). Histopathological examination showed a higher severity of brain lesions in BCG-SARS-CoV-2 challenged mice, mainly consisting of neuroinflammation, increased glial cell population and neuronal degeneration, from 5 dpi onwards. This group also presented higher interstitial pneumonia and vascular thrombosis in lungs (3–4 dpi), BCG-SARS-CoV-2 mice showed higher values for TNF-α and D-dimer values, while iNOS values were higher in SARS-CoV-2 mice at 3–4 dpi. Results presented in this study indicate that BCG stimulation could have intensified the inflammatory and neurodegenerative lesions promoting virus neuroinvasion and dissemination in this experimental model. Although k18-hACE2 mice show higher hACE2 expression and neurodissemination, this study suggests that, although the benefits of BCG on enhancing heterologous protection against pathogens and tumour cells have been broadly demonstrated, potential adverse outcomes due to the non-specific effects of BCG should be considered.